Skip to content

ARSEUS LAB: what changed

BE 0450.810.171NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2023 and 2024

Net result for the year
€228,254
2023 · €150,565+€77,690
Equity
€3.1m
2023 · €2.9m+€228,254
Cash
€262,061
2023 · €215,965+€46,096
Balance sheet total
€6.2m
2023 · €6.8m-€649,140

Largest movements

2023 to 2024
Assets
  • Receivables within one year -€616,816

    down €616,816 (-22.7%), from €2.7m to €2.1m

    of which Trade receivables: -€624,711

  • Stocks and contracts -€70,891

    down €70,891 (-58.2%), from €121,878 to €50,988

Equity and liabilities
  • Short-term financial debts -€1.0m

    down €1.0m (-50.5%), from €2.0m to €1.0m

  • Trade debts +€301,240

    up €301,240 (+27.0%), from €1.1m to €1.4m

  • Profit (loss) carried forward +€228,254

    up €228,254 (+8.8%), from -€2.6m to -€2.4m

  • Tax, wage and social debts -€132,803

    down €132,803 (-23.4%), from €568,438 to €435,635

    of which Taxes: -€96,854

Income statement
  • Goods and materials +€452,842

    up €452,842 (+6.4%), from €7.1m to €7.5m

    of which Change in stocks: decrease (increase): +€385,709

  • Turnover +€354,628

    up €354,628 (+3.6%), from €9.9m to €10.2m

  • Write-downs -€320,209

    down €320,209, from €65,679 to -€254,529

  • Other operating income +€251,961

    up €251,961 (+19.1%), from €1.3m to €1.6m

  • Other operating charges +€190,672

    up €190,672 (+44.8%), from €425,884 to €616,556

Change in the result, 2023 to 2024

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2023 €150,565
Turnover +€354,628
Other operating income +€251,961
Goods and materials -€452,842
Services and other goods -€155,554
Staff costs -€62,421
Depreciation +€2,916
Write-downs +€320,209
Other operating charges -€190,672
Financial income +€11,136
Financial charges -€2,375
Taxes +€705
Result 2024 €228,254
raises the resultlowers the result

Derived cash bridge

cash 2023 to 2024

The bridge is derived from the 2023 and 2024 balance sheets and the 2024 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€1.1m
Investment -€23,244
Financing -€1.0m
Cash 2023 €215,965
Net result for the year +€228,254
Depreciation +€24,283
Stocks and contracts +€70,891
Receivables within one year +€616,816
Deferred charges and accrued income +€6,490
Trade debts +€301,240
Tax, wage and social debts -€132,803
Other debts +€1,094
Accrued charges and deferred income -€17,614
Investment in fixed assets (net) -€23,244
Short-term financial debts -€1.0m
Cash 2024 €262,061
brings cash intakes cash out
Every line side by side 69 lines
Line Code 2023 2024 Change %
Total assets 20/58 €6,810,837 €6,161,697 -€649,140 -9.5%
Fixed assets 21/28 €3,742,163 €3,741,125 -€1,039 0.0%
Intangible fixed assets 21 €43,191 €66,493 +€23,302 +54.0%
Tangible fixed assets 22/27 €30,398 €6,057 -€24,341 -80.1%
Plant, machinery and equipment 23 €23,894 - -€23,894
Furniture and vehicles 24 €6,503 €6,057 -€447 -6.9%
Financial fixed assets 28 €3,668,575 €3,668,575 = 0.0%
Affiliated companies 280/1 €3,668,100 €3,668,100 = 0.0%
Participating interests 280 €3,668,100 €3,668,100 = 0.0%
Other financial fixed assets 284/8 €475 €475 = 0.0%
Amounts receivable and cash guarantees 285/8 €475 €475 = 0.0%
Current assets 29/58 €3,068,674 €2,420,573 -€648,101 -21.1%
Stocks and contracts in progress 3 €121,878 €50,988 -€70,891 -58.2%
Stocks 30/36 €121,878 €50,988 -€70,891 -58.2%
Goods purchased for resale 34 €121,878 €50,988 -€70,891 -58.2%
Amounts receivable within one year 40/41 €2,719,356 €2,102,540 -€616,816 -22.7%
Trade receivables 40 €2,715,640 €2,090,929 -€624,711 -23.0%
Other amounts receivable 41 €3,716 €11,610 +€7,895 +212%
Cash at bank and in hand 54/58 €215,965 €262,061 +€46,096 +21.3%
Deferred charges and accrued income 490/1 €11,475 €4,985 -€6,490 -56.6%
Total equity and liabilities 10/49 €6,810,837 €6,161,697 -€649,140 -9.5%
Equity 10/15 €2,907,376 €3,135,630 +€228,254 +7.9%
Contributions 10/11 €5,492,961 €5,492,961 = 0.0%
Capital 10 €5,492,961 €5,492,961 = 0.0%
Issued capital 100 €20,492,961 €20,492,961 = 0.0%
Uncalled capital 101 €15,000,000 €15,000,000 = 0.0%
Reserves 13 €9,296 €9,296 = 0.0%
Non-distributable reserves 130/1 €9,296 €9,296 = 0.0%
Legal reserve 130 €9,296 €9,296 = 0.0%
Profit (loss) carried forward 14 -€2,594,881 -€2,366,627 +€228,254 +8.8%
Amounts payable 17/49 €3,903,461 €3,026,067 -€877,394 -22.5%
Amounts payable within one year 42/48 €3,722,189 €2,862,409 -€859,780 -23.1%
Financial debts 43 €2,038,214 €1,008,903 -€1.0m -50.5%
Credit institutions 430/8 €2,038,214 €1,008,903 -€1.0m -50.5%
Trade debts 44 €1,115,537 €1,416,777 +€301,240 +27.0%
Suppliers 440/4 €1,115,537 €1,416,777 +€301,240 +27.0%
Taxes, remuneration and social security 45 €568,438 €435,635 -€132,803 -23.4%
Taxes 450/3 €301,619 €204,765 -€96,854 -32.1%
Remuneration and social security 454/9 €266,819 €230,871 -€35,949 -13.5%
Other amounts payable 47/48 - €1,094 +€1,094
Accrued charges and deferred income 492/3 €181,272 €163,658 -€17,614 -9.7%
Operating income 70/76A €11,169,329 €11,775,917 +€606,588 +5.4%
Turnover 70 €9,853,528 €10,208,156 +€354,628 +3.6%
Other operating income 74 €1,315,800 €1,567,761 +€251,961 +19.1%
Non-recurring operating income 76A €0 €0 =
Operating charges 60/66A €10,894,639 €11,433,003 +€538,364 +4.9%
Goods for resale, raw materials and consumables 60 €7,069,816 €7,522,658 +€452,842 +6.4%
Purchases 600/8 €7,117,148 €7,184,281 +€67,133 +0.9%
Change in stocks: decrease (increase) 609 -€47,332 €338,377 +€385,709
Services and other goods 61 €1,626,869 €1,782,423 +€155,554 +9.6%
Remuneration, social security and pensions 62 €1,679,192 €1,741,613 +€62,421 +3.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €27,199 €24,283 -€2,916 -10.7%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €65,679 -€254,529 -€320,209
Other operating charges 640/8 €425,884 €616,556 +€190,672 +44.8%
Operating profit (loss) 9901 €274,690 €342,914 +€68,224 +24.8%
Financial income 75/76B €1,681 €12,817 +€11,136 +662%
Recurring financial income 75 €1,681 €1,690 +€8 +0.5%
Income from current assets 751 €743 €1,604 +€861 +116%
Other financial income 752/9 €939 €86 -€853 -90.8%
Non-recurring financial income 76B - €11,127 +€11,127
Financial charges 65/66B €124,016 €126,391 +€2,375 +1.9%
Recurring financial charges 65 €124,016 €126,391 +€2,375 +1.9%
Debt charges 650 €81,025 €92,591 +€11,567 +14.3%
Other financial charges 652/9 €42,991 €33,800 -€9,192 -21.4%
Profit (loss) for the period before taxes 9903 €152,355 €229,340 +€76,985 +50.5%
Income taxes 67/77 €1,791 €1,086 -€705 -39.4%
Taxes 670/3 €1,791 €1,086 -€705 -39.4%
Profit (loss) for the period 9904 €150,565 €228,254 +€77,690 +51.6%
Profit (loss) for the period to be appropriated 9905 €150,565 €228,254 +€77,690 +51.6%

Value

latest balance sheet 28-12-2024 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€2.3m to €2.6m

Midpoint €2.4m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €3.1m
Capitalised earnings €1.5m to €2.1m
Indication €2.3m to €2.6m

Adjusted equity

balance sheet 28-12-2024
Equity (10/15)
€3,135,630
Intangible fixed assets (21)
-€66,493
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€3.1m

Capitalised earnings

net result for the year (9904)
2024
€228,254
excluding non-recurring income and charges
€217,127
2023
€150,565
2022
€252,211
2021
€162,698
excluding non-recurring income and charges
€130,655
2020
-€120,702
Average result, excluding non-recurring income and charges
€206,634
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.5m / €1.7m / €2.1m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 December 2023 and 28 December 2024. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.